Investigating genetic features of TDP-43 related diseases
Shared and disparate genomic features of TDP-43 proteinopathies
This study is looking at how certain genes and brain changes are connected in conditions like ALS and frontotemporal dementia, hoping to find out how these factors affect each person's experience with the disease, which could help create more tailored treatments for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10877872 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic and pathological characteristics of TDP-43 proteinopathies, which include conditions like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). By examining the shared and unique features of these diseases, the research aims to uncover the underlying molecular mechanisms that contribute to their clinical variability. Patients may benefit from insights into how genetic factors influence their specific condition, potentially leading to more personalized treatment approaches. The study employs a combination of genetic analysis and clinical assessments to explore these relationships.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with ALS, frontotemporal dementia, or related TDP-43 proteinopathies.
Not a fit: Patients with other neurodegenerative diseases not related to TDP-43 proteinopathies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with ALS and related cognitive disorders.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Spencer, Barbara Elizabeth — University of Pennsylvania
- Study coordinator: Spencer, Barbara Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.